Analystreport

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) is now covered by analysts at Wedbush. They set a "neutral" rating and a $5.00 price target on the stock.

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com